RxDoctor Payments Data

Harold Hill, MD

Family Medicine · Hot Springs, ARNPI 1215916861

Payments from drug & device makers

$5,393in general payments, 2019–2025

Across 381 payments — averaging $14.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • GSK$857
  • AstraZeneca$602
  • Pfizer$596
  • Amgen$444
  • Lilly USA, LLC$178
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$5,392100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,393 in reported general payments places this provider in the 85th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$140,775
Medicare patients
948
Services billed
12,081

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban112$89,060
FarxigaDapagliflozin Propanediol61$58,624
OzempicSemaglutide46$50,240
JardianceEmpagliflozin29$35,775
JanuviaSitagliptin Phosphate35$31,850
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$24,993
LinzessLinaclotide24$11,784
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen500$11,080
Breo ElliptaFluticasone/Vilanterol25$9,527
JanumetSitagliptin Phos/Metformin Hcl12$7,553
Omeprazole495$6,832
Gabapentin329$5,988
Combivent RespimatIpratropium/Albuterol Sulfate12$5,775
Aripiprazole68$5,608
SymbicortBudesonide/Formoterol Fumarate15$5,236

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$596$89,060112 claims
AstraZenecaFarxiga, Symbicort$602$63,86076 claims
Novo NordiskOzempic$141$50,24046 claims
Boehringer IngelheimJardiance, Combivent Respimat$110$41,54941 claims
MerckJanuvia, Janumet$72$39,40347 claims
GSKTrelegy Ellipta, Breo Ellipta$857$34,51952 claims
AbbVieLinzess, Synthroid$1,003$14,14155 claims
NovartisEntresto$58$4,50311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Hot Springs

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →